Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

156.90
-0.8000-0.51%
Post-market: 156.900.0012+0.00%18:33 EDT
Volume:3.04M
Turnover:476.93M
Market Cap:243.35B
PE:23.49
High:158.80
Open:158.46
Low:156.41
Close:157.70
52wk High:212.71
52wk Low:153.41
Shares:1.55B
Float Shares:1.50B
Volume Ratio:1.19
T/O Rate:0.20%
Dividend:3.16
Dividend Rate:2.02%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:4.84
PE(LYR):23.99

Loading ...

AstraZeneca Reports 'Meaningful Improvement' in Phase 3 Study of Lung Cancer Patients

MT Newswires Live
·
Sep 01

AstraZeneca Says Breast Cancer Combo Approved in EU; Completes Acquisition of License for Lung Cancer Treatment

MT Newswires Live
·
Sep 01

Movement Alert|AstraZeneca PLC Declines 4.14% Overnight, Competitive Threat From Summit Ivosdenib Data Weighs on Immuno-Oncology Outlook

Market Focus
·
Sep 01

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 01

Hutchmed Says Lung Cancer Therapy Improves Progression-Free Survival in China Phase 3 Trial

MT Newswires Live
·
Aug 31

AstraZeneca PLC Stock Falls Friday, Underperforms Market

Dow Jones
·
Aug 29

Jefferies sees neutral to negative read-through to Alnylam from AstraZeneca data

TIPRANKS
·
Aug 28

AstraZeneca Targets Pediatric Asthma Gains With New Glycopyrronium Trial

TIPRANKS
·
Aug 28

AstraZeneca Advances Off‑the‑Shelf CAR‑T Program in Tough‑to‑Treat Multiple Myeloma

TIPRANKS
·
Aug 28

Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements

TIPRANKS
·
Aug 27

Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints

TIPRANKS
·
Aug 27

AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients

MT Newswires Live
·
Aug 27

AstraZeneca's Tezspire Meets Esophagitis Late-Stage Trial Goals

Dow Jones
·
Aug 27

AstraZeneca Slides Wednesday, Underperforms Market

Dow Jones
·
Aug 27

AstraZeneca Deepens Its Type 2 Diabetes Pipeline With New Global Patient Mapping Study

TIPRANKS
·
Aug 26

AstraZeneca Climbs Tuesday, Outperforms Market

Dow Jones
·
Aug 26

AstraZeneca (AZN) Receives a Sell from Deutsche Bank

TIPRANKS
·
Aug 25

Astrazeneca Prices $2.97 Billion Eurobond Offering

MT Newswires Live
·
Aug 25

AstraZeneca’s AZD4144 Interaction Study Adds Quiet Support to AZN’s Pipeline Story

TIPRANKS
·
Aug 25

AstraZeneca PLC Stock Falls Monday, Underperforms Market

Dow Jones
·
Aug 25